PERITONEAL CARCINOMATOSIS FROM OTHER GYNECOLOGIC PRIMARY CANCER

Clinical trials for PERITONEAL CARCINOMATOSIS FROM OTHER GYNECOLOGIC PRIMARY CANCER explained in plain language.

Never miss a new study

Get alerted when new PERITONEAL CARCINOMATOSIS FROM OTHER GYNECOLOGIC PRIMARY CANCER trials appear

Sign up with your email to follow new studies for PERITONEAL CARCINOMATOSIS FROM OTHER GYNECOLOGIC PRIMARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo offers hope for patients with inoperable abdominal cancers

Disease control Completed

This study tested a combination of two drugs—nilotinib pills and paclitaxel given through a vein and directly into the abdomen—in 21 adults with cancers that had spread to the lining of the belly and could not be surgically removed. The goal was to shrink the tumors enough to all…

Matched conditions: PERITONEAL CARCINOMATOSIS FROM OTHER GYNECOLOGIC PRIMARY CANCER

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 16, 2026 12:49 UTC

PERITONEAL CARCINOMATOSIS FROM OTHER GYNECOLOGIC PRIMARY CANCER

Get alerted when new PERITONEAL CARCINOMATOSIS FROM OTHER GYNECOLOGIC PRIMARY CANCER trials appear

New combo offers hope for patients with inoperable abdominal cancers